Description: This presentation is an open forum from the 1991 Annual Meeting of the Society of Actuaries, held October 20-23 in Toronto. The panelists, including a member of the Association of Life Insurance Medical Directors, and a vice president of the largest insurance testing lab, Home Office Reference Lab, discuss new underwriting technologies, including genetic testing, alternative AIDS testing methods, and the legal and other implications. Discussion from participants is included. From the Record of Society of Actuaries, Volume 17, No. 4A.

Description: 1993 SOA Spring Meeting, Boston. In this session the panelists discussed the new standard valuation law. Areas covered included: 1. Risk of legal liability? 2. Vagueness of actuarial standards? 3. Reliance on other company experts? 4. Consultants versus company actuary perspectives? 5. The science versus the art of the process?

Description: Presented at May 19996 Spring Meeting. This session focuses on emerging compensation plans in the life insurance industry: levelized commissions, potential changes in NY regulations, compensation in alternative channels, salaried agents, innovative programs.

Description: This presentation from Session 20PD of the SOA 1996 Orlando Annual Meeting examines the major trends in insurance laboratory testing from 1980 to 1985, with an emphasis on why blood testing thresholds were lowered dramatically in the mid-1980s and why those thresholds will persist into the next century. The value of liver function testing is examined as a case study in protective value. Issues addressed include: 1. What is the real impact of human immunodeficiency virus [HIV]-1 testing [sentinel effect]? 2. The unique pay-offs from liver function tests, 3. Clinical medicine mortality versus underwritten mortality: overcoming problems caused by different perspectives, and 4. Cotinine pays the freight? From the Record of the Society of Actuaries, Vol. 22, No. 3.

Description: Panelists discuss the implications of marketing ethics on smaller companies as they relate to large company sales practice litigation. From the Record of the Society of Actuaries, Vol. 23, No. 3.

Description: The purpose of this paper is not to present a revolutionary new concept, instead, it is to reexamine a familiar concept in the light of new market circumstances and, to consider the consequences to the life insurance industry if the concept were adopted.

Description: This paper outlines the limitations inherent in current actuarial pricing techniques and describes a product development process that can produce optimal decisions in competitive environments. From Product Development Section Monograph, M-AS99-3.

Description: Discussion of solvency problems and the actuary's role in addressing them in the life insurance industry.

Description: In session 75 PD of the New York Annual Meeting panelists explore practical considerations of maintaining compliance with federal income tax definition of life insurance rules. From the Record of the Society of Actuaries, Vol. 24, No. 3.

Description: From session 63 PD at the Spring regional meeting of the Society of Actuaries held in Atlanta, Georgia, May 24-25, 1999, panelists discuss current issues including adoption status and proposals for various regulations critical to product development efforts. Impact of XXX on product design and reserves is also discussed. From the Record of the Society of Actuaries, Vol. 25, No. 1.